Table 10.

Single-arm studies of interferon-α (IFN-α) plus low-dose cytarbine.

% Cytogenetic Response
Study (reference)
No. Treated
% CHR
Complete
Major
MDACC(89)     
daily cytarabine   134   92   31   50  
intermittent cytarabine   54   84   20   38  
Arthur(91)  30   93   30   53  
Thaler(92)  84   54   18   25  
Silver(93)  88   72   15   51  
Abbreviations: CHR, complete hematologic response; MDACC, M.D. Anderson Cancer Center  
% Cytogenetic Response
Study (reference)
No. Treated
% CHR
Complete
Major
MDACC(89)     
daily cytarabine   134   92   31   50  
intermittent cytarabine   54   84   20   38  
Arthur(91)  30   93   30   53  
Thaler(92)  84   54   18   25  
Silver(93)  88   72   15   51  
Abbreviations: CHR, complete hematologic response; MDACC, M.D. Anderson Cancer Center  
Close Modal

or Create an Account

Close Modal
Close Modal